How BioWave neurostimulation works.
BioWave’s patented smarter pain blocking technology provides immediate, deep, long-lasting relief of severe pain. BioWave devices deliver therapeutic electrical signals through skin directly to pain nerves in deep tissue to prevent pain from reaching the brain, relieving chronic, acute, or post-operative pain. BioWave technology provides 8 hours of pain relief on average following a 30-minute treatment* and is easy to use both at home and on the go.
A recent study published in the journal, Pain and Therapy, confirms that BioWave® noninvasive neurostimulation is an effective treatment for chronic pain. Patients reported significant pain reduction and improvements in their ability to perform daily activities, such as walking, standing, and sleeping. 42% of the group reported that they reduced or eliminated the use of pain medication after using BioWave® for two weeks.
How prevalent is chronic pain?
“Globally, it has been estimated that 1 in 5 adults suffer from pain and that another 1 in 10 adults are diagnosed with chronic pain each year.”1 This is considered the most overlooked health issue affecting people’s quality of life.
Although the usual treatment of prescribing pain medications has been the standard of care, there are many drawbacks. These include side effects and addiction to opioids. The need for a noninvasive method that focuses on the peripheral nervous system (PNS, nerves that branch out from the brain and spinal cord) is clearly needed. It is safe and effective and ultimately avoids the side effects of opioids.
The paper, ‘Reduced Pain and Improved Function Following Short-Term Use of Noninvasive BioWave High Frequency Peripheral Nerve Stimulation for Pain Management’ featured the study with a large population or 1511 patients who used BioWaveHOME® device to treat chronic pain.
What were the outcomes of this study?
Patients in pain were prescribed BioWave neurostimulation treatment and then offered a 2-week follow-up survey. Some of the metrics the survey addressed were overall pain scores, satisfaction level, desire to continue therapy, medication use, effect on lifestyle (mood, sleep, sit, stand, walk and lift) and activities of daily living.
Patients reported significant pain reduction along with other benefits after using BioWave for two weeks.
- The average reduction in pain scores was47 points (0-10 scale), which is a statistically significant reduction.
- An improvement in quality of life was reported by 87.6% of patients.
- 42% of patients reported that they were able to eliminate or reduce their medication use.
- Over 97% of patients wanted to continue BioWave therapy.
- Patients’ lifestyle was improved across the board with almost half of patients reporting bothsleep (47.9%) and mood (47.7%) improvements.
BioWave is a non-opioid, non-surgical alternative to treat chronic pain.
For people who suffer from chronic or acute pain, the hope of living a life free of severe pain, and not having to rely on drugs or invasive treatments that may or may not work, is important. This study confirms that BioWave technology delivers an effective and easy to use pain relief solution for medical providers, patients, and their caregivers looking for a non-opioid/non-surgical pain treatment alternative.